Clinical Trial Update: HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone) [NA]

View source ↗

Summary

A completed clinical trial evaluating classification, measurement, and fat response to the TZD pioglitazone for HIV-associated lipodystrophy (HAL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Hiv-associated Lipodystrophy

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: HIV Infections | NA | Status: COMPLETED | Results posted: 2019-10-08